VanEck Associates’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-669
| Closed | -$12K | – | 1390 |
|
|
2023
Q4 | $12K | Sell |
669
-665
| -50% | -$11.9K | ﹤0.01% | 1342 |
|
|
2023
Q3 | $23K | Buy |
1,334
+784
| +143% | +$13.5K | ﹤0.01% | 1332 |
|
|
2023
Q2 | $7K | Hold |
550
| – | – | ﹤0.01% | 1371 |
|
|
2023
Q1 | $7K | Sell |
550
-10
| -2% | -$127 | ﹤0.01% | 1376 |
|
|
2022
Q4 | $8K | Buy |
560
+226
| +68% | +$3.23K | ﹤0.01% | 1378 |
|
|
2022
Q3 | $3K | Buy |
334
+157
| +89% | +$1.41K | ﹤0.01% | 1366 |
|
|
2022
Q2 | $2K | Buy |
177
+96
| +119% | +$1.09K | ﹤0.01% | 1353 |
|
|
2022
Q1 | $2K | Hold |
81
| – | – | ﹤0.01% | 1356 |
|
|
2021
Q4 | $3K | Hold |
81
| – | – | ﹤0.01% | 1352 |
|
|
2021
Q3 | $3K | Buy |
81
+46
| +131% | +$1.7K | ﹤0.01% | 1278 |
|
|
2021
Q2 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 1268 |
|